Effect of glutamine on glucose metabolism in children with Duchenne muscular dystrophy

Clinical Nutrition

Volumn 32, Issue 3, 2013, Pages 386-390

  Letellier, Guy ^a,b,c   Mok, Elise ^a,b,c   Alberti, Corinne ^a,d,e   De Luca, Arnaud ^b,c   Gottrand, Frédéric ^f   Cuisset, Jean Marie ^g   Denjean, André ^a,d,e   Darmaun, Dominique ^h   Hankard, Régis ^a,b,c  

^a INSERM   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f University of Lille   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h Universite de Nantes   (France)

Author keywords

Body composition; Duchenne muscular dystrophy; Glucose metabolism; Glutamine; HOMA; Insulin sensitivity

Indexed keywords

GLUCOSE; GLUTAMINE; INSULIN; PLACEBO; PREDNISOLONE;

AMINO ACID BLOOD LEVEL; ARTICLE; BODY COMPOSITION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DUCHENNE MUSCULAR DYSTROPHY; FAT MASS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; BLOOD GLUCOSE; BODY COMPOSITION; CHILD; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUTAMINE; HOMEOSTASIS; HUMANS; INSULIN; MALE; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 84877115037     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.08.019     Document Type: Article

References (32)

1. Haymond M.W., Strobel K.E., DeVivo D.C. Muscle wasting and carbohydrate homeostasis in Duchenne muscular dystrophy. Neurology 1978, 28:1224-1231.
2. Nishio H., Wada H., Matsuo T., Horikawa H., Takahashi K., Nakajima T., et al. Glucose, free fatty acid and ketone body metabolism in Duchenne muscular dystrophy. Brain Dev JPN 1990, 12:390-402.
3. Cahill G.F. Starvation in man. N Engl J Med 1970, 282:668-675.
4. Hankard R.G., Haymond M.W., Darmaun D. Role of glutamine as a glucose precursor in fasting humans. Diabetes 1997, 46:1535-1541.
5. Nurjhan N., Bucci A., Perriello G., Stumvoll M., Dailey G., Bier D.M., et al. Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man. J Clin Invest 1995, 95:272-277.
6. Hankard R.G., Hammond D., Haymond M.W., Darmaun D. Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy. Pediatr Res 1998 Feb, 43(2):222-226.
7. Mok E., Eleouet-Da Violante C., Daubrosse C., Gottrand F., Rigal O., Fontan J.E., et al. Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy. Am J Clin Nutr 2006 Apr, 83(4):823-828.
8. Mok E., Letellier G., Cuisset J.M., Denjean A., Gottrand F., Alberti C., et al. Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial. PloS One 2009, 4(5):e5448.
9. Hankard R.G., Haymond M.W., Darmaun D. Effect of glutamine on leucine metabolism in humans. Am J Physiol 1996 Oct, 271(4 Pt 1):E748-E754.
10. Hankard R., Mauras N., Hammond D., Haymond M., Darmaun D. Is glutamine a 'conditionally essential' amino acid in Duchenne muscular dystrophy?. Clin Nutr 1999 Dec, 18(6):365-369.
11. Hankard R.G., Darmaun D., Sager B.K., D'Amore D., Parsons W.R., Haymond M. Response of glutamine metabolism to exogenous glutamine in humans. Am J Physiol 1995 Oct, 269(4 Pt 1):E663-E670.
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 Jul, 28(7):412-419.
13. Keskin M., Kurtoglu S., Kendirci M., Atabek M.E., Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005 Apr, 115(4):e500-e503.
14. Sempé M., Pédron G., Roy-Pernot M.P. Auxologie, Méthode et séquences 1979, Théraplix, Paris.
15. Rolland-Cachera M.F., Cole T.J., Sempé M., Tichet J., Rossignol C., Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991, 45:13-21.
16. Mok E., Beghin L., Gachon P., Daubrosse C., Fontan J.E., Cuisset J.M., et al. Estimating body composition in children with Duchenne muscular dystrophy: comparison of bioelectrical impedance analysis and skinfold-thickness measurement. Am J Clin Nutr 2006 Jan, 83(1):65-69.
17. Greenfield J.R., Farooqi I.S., Keogh J.M., Henning E., Habib A.M., Blackwood A., et al. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. Am J Clin Nutr 2009 Jan, 89(1):106-113.
18. Henquin J.C., Dufrane D., Nenquin M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes 2006 Dec, 55(12):3470-3477.
19. Bier D.M., Leake R.D., Haymond M.W., Arnold K.J., Gruenke L.D., Sperling M.A., et al. Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977 Nov, 26(11):1016-1023.
20. des Robert C., Le Bacquer O., Piloquet H., Roze J.C., Darmaun D. Acute effects of intravenous glutamine supplementation on protein metabolism in very low birth weight infants: a stable isotope study. Pediatr Res 2002 Jan, 51(1):87-93.
21. Perriello G., Nurjhan N., Stumvoll M., Bucci A., Welle S., Dailey G., et al. Regulation of gluconeogenesis by glutamine in normal postabsorptive humans. Am J Physiol 1997 Mar, 272(3 Pt 1):E437-E445.
22. Thibault R., Welch S., Mauras N., Sager B., Altomare A., Haymond M., et al. Corticosteroids increase glutamine utilization in human splanchnic bed. Am J Physiol Gastrointest Liver Physiol 2008 Feb, 294(2):G548-G553.
23. Hankard R., Gottrand F., Turck D., Carpentier A., Romon M., Farriaux J.P. Resting energy expenditure and energy substrate utilization in children with Duchenne muscular dystrophy. Pediatr Res 1996 Jul, 40(1):29-33.
24. Mok E., Constantin B., Favreau F., Neveux N., Magaud C., Delwail A., et al. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice. Pediatr Res 2008 Mar, 63(3):268-273.
25. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979 Sep, 237(3):E214-E223.
26. Allard P., Delvin E.E., Paradis G., Hanley J.A., O'Loughlin J., Lavallee C., et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem 2003 Apr, 49(4):644-649.
27. Bakalar B., Duska F., Pachl J., Fric M., Otahal M., Pazout J., et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006, 34:381-386.
28. Grau T., Bonet A., Miñambres E., Piñeiro L., Irles J.A., Robles A., et al. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 2011, 39:1263-1268.
29. Groh S., Zong H., Goddeeris M.M., Lebakken C.S., Venzke D., Pessin J.E., et al. Sarcoglycan complex: implications for metabolic defects in muscular dystrophies. J Biol Chem 2009 Jul 17, 284(29):19178-19182.
30. Sordella R., Jiang W., Chen G.C., Curto M., Settleman J. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 2003 Apr 18, 113(2):147-158.
31. Mulvey C., Harno E., Keenan A., Ohlendieck K. Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophin-nitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat. Eur J Cell Biol 2005 Nov, 84(11):867-883.
32. Le Bacquer O., Mauras N., Welch S., Haymond M., Darmaun D. Acute depletion of plasma glutamine increases leucine oxidation in prednisone-treated humans. Clin Nutr 2007, 26:231-238.